Boehringer Ingelheim expanded its partnership with AI drug discovery company Owkin to target oncology and immunology, using federated learning across hospital data networks to find new drug targets.
Zealand Pharma struck a deal worth up to $1.2 billion with AI protein-design company Generate Biomedicines to pursue new obesity treatments, joining a wave of major AI drug discovery partnerships.
Doctors and lawyers are earning up to $400 an hour training AI models with their domain expertise, a fast-growing gig market raising new questions about ethics, quality control, and long-term risk.
AI drug discovery company Iambic Therapeutics completed a $150 million IPO with shares rising, showing investor appetite for AI-native biotechs even as the sector awaits its first approved medicine.
KKR-backed Catalio Capital is seeking $500 million for its second AI healthcare investment fund, a sign specialized healthcare AI investing has stayed resilient even as broader AI funding grows choosier.
Big pharma has committed billions to AI drug discovery deals, but no AI-designed drug has yet reached the market, leaving a growing gap between investment enthusiasm and proven clinical payoff.
Aidoc's CARE foundation model won FDA clearance for 11 new CT triage indications, bringing its total to 14, and the company followed with a $150 million Series E that pushed its total funding past $500 million.
ARPA-H is putting $62.7 million behind ADVOCATE, a push to build the first FDA-authorized autonomous AI agent for heart failure care, with Tempus AI, Updoc and Atman Health racing toward a two-year authorization deadline.
India's MeitY Secretary said AI can expand healthcare accessibility and improve diagnosis nationwide, comments reflecting the government's growing emphasis on AI as a tool to address the country's rural doctor shortage.
Utah launched a pilot allowing patients to receive AI-generated prescriptions for topical acne medication without an in-person visit, even as the state's medical board separately moves to suspend a different AI prescribing program over safety concerns.